ChinaDaily Briefs

China: Guodian Technology & Environment Group, 21Vianet Group, Pharmaron Beijing Co Ltd-H, Medco Energi and more

In today’s briefing:

  • Guodian’s H Share Class Meeting on 20 May, IFA Opinion
  • Merger Arb Mondays (2 May) – Dongzheng AFC, Yashili, VNET, Sezzle, Link, Ramsay
  • Pharmaron Beijing Co Ltd (3759.HK/300759.CH) 2022/2021Q1 Results- Expectations Coexist with Concerns
  • Morning Views Asia: Guangzhou R&F Properties, Medco Energi

Guodian’s H Share Class Meeting on 20 May, IFA Opinion

By Arun George

  • Guodian Technology & Environment Group (1296 HK)‘s composite document is out with the H Shareholders’ class meeting on 20 May. The IFA considers the offer to be fair and reasonable. 
  • The key condition for the privatisation is approval by at least 75% of independent H-shareholders (<10% of all independent H-shareholders rejection). There is no minimum acceptance condition. 
  • The H Shareholder with a blocking stake has provided an irrevocable. For a 9 June payment, the gross and annualised spread to the offer is 1.9% and 19.5%, respectively. 

Merger Arb Mondays (2 May) – Dongzheng AFC, Yashili, VNET, Sezzle, Link, Ramsay

By Arun George


Pharmaron Beijing Co Ltd (3759.HK/300759.CH) 2022/2021Q1 Results- Expectations Coexist with Concerns

By Xinyao (Criss) Wang

  • As one of the few CXOs in the industry that has layout of the whole industry chain, Pharmaron carries many expectations. But it cannot compete with WuXi AppTec so far.
  • If Pharmaron could make breakthrough either in its CMC services (improving gross profit margin and scale) or the CGT services, the Company’s outlook and valuation logic would improve greatly.
  • The valuation of Pharmaron should be lower than WuXi AppTec and WuXi Biologics, but higher than Asymchem, Tigermed and Joinn. Considering the macro uncertainties, short-term trades are advised.

Morning Views Asia: Guangzhou R&F Properties, Medco Energi

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Before it’s here, it’s on Smartkarma